Author Archives: Danzig

Global $4.88 Bn CRISPR & Cas Genes Market to 2027: Opportunities in the Expanding Gene & Cell Therapy Area & Government Fund In Genomic R&D – Yahoo…

Posted on by

Dublin, Sept. 21, 2020 (GLOBE NEWSWIRE) -- The "Global CRISPR & Cas Genes Market Size, Share & Trends Analysis by Product & Service (Vector-based Cas, DNA-free Cas, Cell Line Engineering), Application, End Use, and Segment Forecasts 2020-2027" report has been added to ResearchAndMarkets.com's offering.

The global clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) genes market size is expected to reach USD 4.88 billion by 2027, expanding at a CAGR of 16.6% from 2020 to 2027.

CRISPR & Cas Genes Market Report Highlights

The product segment is anticipated to dominate the market throughout the forecast period. This is attributed to the presence of enhanced individual products that can serve multiple purposes including genome engineering, specific genome cleavage using gRNAs, easy gene knockouts, along with reduced off-target cutting, and increased specificity

Cell line engineering services accounted for the largest market share in 2019. The development of this technology has simplified the genome engineering process to a large extent

In biomedical applications, genome engineering held the largest revenue share in 2019 as a result of an increase in the adoption of genome editing techniques for modifications in germline and therapeutics development

Recent advancements in CRISPR/Cas genome editing allow targeted modification in crops, thereby promising crop improvement and revenue generation in the market

A significant number of research studies carried out to develop disease-specific novel therapies and the presence of a huge clinical pipeline that integrates the application of this gene-editing technology are expected to boost revenue generation for the biotechnology and pharmaceutical companies segment

Asia Pacific is anticipated to witness the fastest growth over the forecast period. China holds a significant position in the CRISPR market and is increasingly exploring genome-editing for the development of medicines. The country has launched several CRISPER-based clinical trials, especially for cancer treatment.

Rise in the adoption of CRISPR technology in epigenetics, therapeutics, human germline editing, plant genome editing, and other fields of biotechnology is expected to drive the market.

Presence of a large number of service providers that provide knockout, knock-in, gene repression, gene activation, and other cell line engineering services propel the growth of cell line engineering services. In biomedical applications, genome engineering held the largest revenue share in 2019. Adoption of gene editing techniques for human- and non-human-based genomic engineering is one of the key factors that drive the segment.

The molecular scissor can facilitate the detection of viruses, allowing the development of cost-effective, robust, and rapid point-of-care diagnostics. It allows the detection of viruses at a level of molecular concentration that researchers rarely assess. Sherlock Bioscience estimated that a CRISPR-powered diagnostic test would be available in the future at a reasonable price. In recent times, the most important innovation has been the development of a test for COVID-19.

In March 2020, Mesa Biotech announced FDA authorization for its Accula device, a hand-held COVID-19 diagnostic test. Similarly, in April 2020, CSIR lab announced the development of a paper-strip test for Covid-19 that uses CRISPR-Cas9 to target and identifies the genomic sequences of the virus. Unlike the PCR tests, this test is available at a very low price, USD 6.59 (INR 1 = USD 0.013). Therefore, such initiatives are expected to encourage other players to leverage this crisis and launch novel products.

Key Topics Covered:

Story continues

Chapter 1 Research Methodology

Chapter 2 Executive Summary2.1 Market Snapshot, 2019 (USD Million)

Chapter 3 Crispr And Cas Genes Market Variables, Trends & Scope3.1 Market Trends & Outlook3.2 Market Segmentation & Scope3.3 Market Lineage Outlook3.3.1 Parent Market Outlook3.3.2 Related/Ancillary Market Outlook3.4 Crispr And Cas Genes: Patent Landscape3.4.1 By End - Use Settings3.4.2 By Variants Of Crispr Enzymes3.5 Penetration And Growth Prospect Mapping, By Biomedical Applications, 20193.6 Potential Threat Analysis To Crispr Technology3.6.1 Variations In The Crispr System3.7 Investors Perspective Analysis3.8 User Perspective Analysis3.9 Technology Mapping In Crispr Genome Editing Workflow3.10 Developments And Innovations For Analysis Of Off - Target Effects3.11 Crispr Technologies: Clinical Penetration3.11.1 Human Therapeutics3.11.2 Diagnostics3.11.3 Microbiome Research And Drug Resistance3.11.4 Animal Disease Models

Chapter 4 Industry Outlook4.1 Market Dynamics4.1.1 Market Driver Analysis4.1.1.1 Rising Adoption In Diverse Fields Of Biotechnology4.1.1.1.1 Epigenetics4.1.1.1.2 Medicine4.1.1.1.3 Human Germline Editing4.1.1.1.4 Tool For Qualitative And Quantitative Plant Genome Editing4.1.1.2 Technological Advancements In Crispr4.1.1.3 Introduction Of Anti - Crispr Protein4.1.1.4 Ongoing Competition For Crispr Commercialization4.1.2 Market Restraint Analysis4.1.2.1 Off - Target Effects Of Crispr Technology4.1.2.2 Intellectual Property Disputes Pertaining To Cas4.1.2.3 Ethical Concerns And Implications With Respect To Human Genome Editing4.1.3 Market Opportunity Analysis4.1.3.1 Expanding Gene & Cell Therapy Area4.1.3.2 Government Fund In Genomic R&D4.1.4 Market Challenge Analysis4.1.4.1 Risks Pertaining To The Usage Of Genetically Modified Food4.2 Policy Making & Regulation For Genetic Modification Using Crispr4.3 Porter's Five Forces Analysis4.4 SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)

Chapter 5 Competitive Landscape5.1 Companies (Diagnostic & Drug Developers) Leveraging Gene Editing Technologies5.2 Major Deals & Strategic Alliances Analysis5.3 Market Entry Strategies5.3.1 Crispr Therapeutics: Business Translation5.3.2 Crispr Gene Editing Companies' Toolboxes5.4 Crispr And Cas Genes Market: Pipeline Analysis5.4.1 Editas Medicine5.4.2 Intellia Therapeutics, Inc.5.4.3 Crispr Therapeutics5.4.4 Caribou Biosciences, Inc.5.4.5 Egenesis5.4.6 Beam Therapeutics5.4.7 Ksq Therapeutics5.4.8 Cibus

Chapter 6 Product & Service Business Analysis6.1 Crispr And Cas Genes Market: Product & Service Movement Analysis6.2 By Product6.2.1 Global Crispr And Cas Genes Products Market, 2016 - 2027 (USD Million)6.2.2 Kits & Enzymes6.2.3 Global Crispr And Cas Genes Kits And Enzymes Market, 2016 - 2027 (USD Million)6.2.3.1 Vector - Based Cas96.2.3.2 Dna - Free Cas96.2.4 Libraries6.2.5 Design Tools6.2.6 Antibodies6.2.7 Others6.3 By Service6.3.1 Global Crispr And Cas Genes Service Market, 2016 - 2027 (USD Million)6.3.2 Cell Line Engineering6.3.3 Grna Design6.3.4 Microbial Gene Editing6.3.5 Dna Synthesis

Chapter 7 Application Business Analysis7.1 Crispr And Cas Genes Market: Application Movement Analysis7.2 Biomedical7.2.1 Global Crispr And Cas Genes Market For Biomedical, 2016 - 2027 (USD Million)7.2.2 Genome Engineering7.2.3 Disease Model Studies7.2.4 Functional Genomics7.2.5 Epigenetics7.2.6 Others7.3 Agriculture

Chapter 8 End - Use Business Analysis8.1 Crispr And Cas Genes Market: End - Use Movement Analysis8.1.1 Biotechnology & Pharmaceutical Companies8.1.2 Academics & Government Research Institutes8.1.3 Contract Research Organizations (Cros)

Chapter 9 Regional Business Analysis

Chapter 10 Company Profiles

Astrazeneca

Addgene

Caribou Biosciences, Inc.

Cellectis

Crispr Therapeutics

Editas Medicine, Inc.

Egenesis

F. Hoffmann - La Roche Ltd.

Horizon Discovery Group Plc

Genscript

Danaher Corporation

Intellia Therapeutics, Inc.

Lonza

Merck Kgaa

New England Biolabs

Takara Bio, Inc.

Thermo Fisher Scientific, Inc.

Synthego

Mammoth Biosciences

Inscripta, Inc.

Cibus

Beam Therapeutics

PlanteditVertex Pharmaceuticals Incorporated

Hera Biolabs

Origene Technologies, In
c.

Recombinetics, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/lypwvp

About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Go here to see the original:
Global $4.88 Bn CRISPR & Cas Genes Market to 2027: Opportunities in the Expanding Gene & Cell Therapy Area & Government Fund In Genomic R&D - Yahoo...

Japan CRISPR/Cas9 Market size and Key Trends in terms of volume and value 2019-2026 – The Daily Chronicle

Posted on by

The research study presented in this report offers complete and intelligent analysis of the competition, segmentation, dynamics, and geographical advancement of the Global Japan CRISPR/Cas9 Market. The research study has been prepared with the use of in-depth qualitative and quantitative analyses of the global Japan CRISPR/Cas9 market. We have also provided absolute dollar opportunity and other types of market analysis on the global Japan CRISPR/Cas9 market.

It takes into account the CAGR, value, volume, revenue, production, consumption, sales, manufacturing cost, prices, and other key factors related to the global Japan CRISPR/Cas9 market. All findings and data on the global Japan CRISPR/Cas9 market provided in the report are calculated, gathered, and verified using advanced and reliable primary and secondary research sources. The regional analysis offered in the report will help you to identify key opportunities of the global Japan CRISPR/Cas9 market available in different regions and countries.

Request Sample Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2795931&source=atm

The authors of the report have segmented the global Japan CRISPR/Cas9 market as per product, application, and region. Segments of the global Japan CRISPR/Cas9 market are analyzed on the basis of market share, production, consumption, revenue, CAGR, market size, and more factors. The analysts have profiled leading players of the global Japan CRISPR/Cas9 market, keeping in view their recent developments, market share, sales, revenue, areas covered, product portfolios, and other aspects.

segment by Type, the product can be split intoGenome EditingGenetic engineeringgRNA Database/Gene LibrarCRISPR PlasmidHuman Stem CellsGenetically Modified Organisms/CropsCell Line Engineering

Market segment by Application, split intoBiotechnology CompaniesPharmaceutical CompaniesAcademic InstitutesResearch and Development Institutes

Based on regional and country-level analysis, the CRISPR/Cas9 market has been segmented as follows:North AmericaUnited StatesCanadaEuropeGermanyFranceU.K.ItalyRussiaNordicRest of EuropeAsia-PacificChinaJapanSouth KoreaSoutheast AsiaIndiaAustraliaRest of Asia-PacificLatin AmericaMexicoBrazilMiddle East & AfricaTurkeySaudi ArabiaUAERest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global CRISPR/Cas9 market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.The key players covered in this studyCaribou BiosciencesIntegrated DNA Technologies (IDT)CRISPR TherapeuticsMerckMirus BioEditas MedicineTakara BioThermo Fisher ScientificHorizon Discovery GroupIntellia TherapeuticsAgilent TechnologiesCellectaGenScriptGeneCopoeiaSynthego

Make An EnquiryAbout This Report @ https://www.researchmoz.com/enquiry.php?type=E&repid=2795931&source=atm

Japan CRISPR/Cas9 Market Size and Forecast

In terms of region, this research report covers almost all the major regions across the globe such as North America, Europe, South America, the Middle East, and Africa and the Asia Pacific. Europe and North America regions are anticipated to show an upward growth in the years to come. While Japan CRISPR/Cas9 Market in Asia Pacific regions is likely to show remarkable growth during the forecasted period. Cutting edge technology and innovations are the most important traits of the North America region and thats the reason most of the time the US dominates the global markets. Japan CRISPR/Cas9 Market in South, America region is also expected to grow in near future.

The Japan CRISPR/Cas9 Market report highlights is as follows:

This Japan CRISPR/Cas9 market report provides complete market overview which offers the competitive market scenario among major players of the industry, proper understanding of the growth opportunities, and advanced business strategies used by the market in the current and forecast period.

This Japan CRISPR/Cas9 Market report will help a business or an individual to take appropriate business decision and sound actions to be taken after understanding the growth restraining factors, market risks, market situation, market estimation of the competitors.

The expected Japan CRISPR/Cas9 Market growth and development status can be understood in a better way through this five-year forecast information presented in this report

This Japan CRISPR/Cas9 Market research report aids as a broad guideline which provides in-depth insights and detailed analysis of several trade verticals.

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2795931&licType=S&source=atm

See the rest here:
Japan CRISPR/Cas9 Market size and Key Trends in terms of volume and value 2019-2026 - The Daily Chronicle

The United Nations has failed: Fixing the world is now up to all of us | TheHill – The Hill

Posted on by

As the United Nations General Assembly opens this week amidst the deadliest pandemic in a century, the worst climate change-induced disasters in millennia, and hundreds of millions of the worlds most vulnerable people falling back into abject poverty, one thing is clear: The United Nations ideal, as envisioned by its founders, has in many important ways failed.

Rather than blame the United Nations and other international organizations for this failure, we need to place blame where it is due on the U.N. member states that, for decades, have excessively defended their national sovereignty at the expense of our common good. Unless we find a way to collectively address our greatest global challenges from pandemics to climate change and ecosystem destruction, from systemic poverty and inequality to proliferating weapons of mass destruction our species will not just be at risk, we could even face extinction.

It was not coincidental that when the COVID-19 crisis began late last year, the World Health Organization (WHO) was caught flat-footed. We live in a world of sovereign states with only a thin overlay of international organizations working tirelessly, but too often in vain, to bring us all together. The WHO could not assessChinese government misinformationor send emergency teams to Wuhan, China, because our states have not given the WHO independent pandemic surveillance and emergency response capabilities for fear that this might compromise national sovereignty. The same basic story can be told for why we cant address so many other global issues.

Thats because, while our biggest problems are global, the ways we have organized to address them are predominantly national. Until we fix this fundamental mismatch, we will be in grave and growing danger. We cant do this by platitudes or by singing songs and waving our smartphones in the air.

In very short order, we humans have gone from being disparate bands of roving nomads to becoming a global species with the awesome power to remake almost every aspect of life on earth. But we have become a global species without developing a global consciousness or politics to match. To safeguard our future, we must change that. We needa new global operating system.

The foundation of this new approach must be a recognition of the mutual responsibilities of our deep global interdependence. Its manifestation must be an empowered and fully inclusive global movement of people of all backgrounds. Our national and international leaders have failed us, so regular people must divide upamong ourselvesthe jobs of buildinga better future or face the consequences of our inaction.

First, we must urgently ramp up the funding, staffing, authority, and global coordinating role of the World Health Organization. At a time when walls are going up around the world, we desperately need an empowered global health organization to operate above them. We dont now have the WHO we need but we can build it up, fast, if we put our collective minds to it.

Second, we must create a powerful new specialized agency within the U.N. focusing on common responses to shared, existential threats. Backed by and coordinating with states, but also operating with a high degree of depoliticized autonomy, this agency would be tasked with identifying and analyzing the greatest risks facing our species and our common home, developing, coordinating and implementing ongoing action plans for addressing them, compiling and sharing best practices from around the world, and leading efforts to build capacity everywhere, to prepare for and seek to prevent future global crises, and coordinating emergency responses when crises do occur.

Third,world leaders, particularly from the G-7 and G-20 counties, must commit to a specific, adequately funded plan to ensure safe drinking water, basic sanitation and essential protection from deadly pandemics to every person on Earth by 2030. This pandemic and its economic impact not only put the worlds most vulnerable populations at risk, it threatens all of us. If the virus grows and mutates anywhere, it poses an increased threat to people everywhere. In this context, calling for a massive, concerted global effort to address the emergency needs of the worlds most vulnerable population is not an act of charity but a pragmatic imperative.

Our world today exists at a crossroads. The pandemic, wildfires, poverty and despair we see around us are indicators of the even worse problems we will face if we dont dramatically change course.

The good news is that a hopeful future awaits us where our collective needs can be far better met. The question for the leaders meeting this week for the UN General Assembly and for all of us is whether we have the imagination and courage to together start building that world.

Jamie Metzlis a technology futurist, a member of the World Health Organizations international advisory committee on human genome editing andthe founder and chairman ofOneShared.World,a global social movement focusing on world collective-action policies.He is the author of five books, including Hacking Darwin: Genetic Engineering and the Future of Humanity (2019). He previously served on the National Security Council and State Department during the Clinton administration and with the United Nations. The views expressed are his own. Follow him on Twitter@jamiemetzl.

Read more here:
The United Nations has failed: Fixing the world is now up to all of us | TheHill - The Hill

Innovation in health and agriculture. We need to think bigger – World Economic Forum

Posted on by

2020 must be considered as a global turning point: the year when a lethal virus shook the global community. Within weeks, the pandemic severely affected our private and professional realities. Hundreds of thousands died. Millions lost their jobs. Entire industries slowed down dramatically. These fundamental changes to public life offer us unprecedented insights into our economy and its impact on our climate.

There is a broad consensus that the way we live and manage our economy is not sustainable. We face an urgent call to action. A large share of that responsibility lies with industrial companies like Bayer because, with our size and strength, we are capable of making a difference.

While this was true way before COVID-19, the pandemic has demonstrated how fundamentally we need to change. Despite the massive restrictions of this year from the postponed Olympics to the virtual UN General Assembly the International Energy Agency expects global CO2 emissions to drop by only 8% from 2019. In other words: large parts of the global economy were severely decelerated and our carbon emissions still remain more than 90% of what they were last year.

My takeaway is that behaviour changes like consuming and travelling less is certainly important, but not enough by far. In light of this pandemic, we can clearly see that we need to think bigger to succeed with the transformation to a sustainable economy. We need new technologies, breakthrough innovation and sustainable business models.

Inside the worlds labs, there is a technological revolution looming in the life sciences. Technologies such as synthetic biology, cell manufacturing, gene editing, artificial intelligence, microbe engineering, and others may change how patients are treated and food is produced.

Five years ago, Bayer decided to set up a separate unit, called Leaps by Bayer, solely focusing on breakthrough innovation with the potential to address some of humanitys biggest challenges. We began with the vision to invest in disruptive technologies that could shift key paradigms in our core business. In health, this means moving from treating, to curing and preventing diseases. In agriculture, its about moving from producing more, to better and more sustainable food.

We set out to address 10 huge challenges, such as curing genetic diseases or developing a sustainable protein supply. Each leap is outstandingly ambitious with the potential to impact millions of lives. In its operating model, Leaps stands for fostering access to cutting-edge technologies by collaborating with biotech start-ups. We have created or invested in more than 30 companies to date. In many cases, we provided not only capital, but access to Bayer resources, expertise and IP.

Each of the ventures in the Leaps portfolio is focused on new technologies that have been identified to best address the challenges. Gene editing, cell therapy, germplasm for vertical farming are only some of the technologies that Leaps has created companies around.

Sustainable organ replacement

One example for gene editings huge promise is in organ replacement. Worldwide, an estimated 1.5 to 2 million people are on organ transplant waiting lists. Only three in 1,000 people die in a way that their organs can be donated.

Kidney failure is one of the main drivers of organ transplant need, with nearly half a million Americans currently on dialysis. What if this diagnosis meant scheduling a prompt transplant operation, with low risks of organ rejection, and skipping dialysis entirely?

Technologies being developed by the Leaps company eGenesis like growing broadly compatible human organs using genetically modified pigs could end the global organ shortage, ensuring that patients everywhere have almost immediate access to life-saving transplants.

The environmental impact of agriculture

Modern agriculture is essential to feed the growing population of around 10 billion by 2050. On the flipside, agriculture is resource intensive, accounting for about a quarter of global greenhouse gas emissions and 70% of global freshwater withdrawals.

What if we could grow crops with significantly reduced farming inputs at reasonable costs? If the Leaps company JoynBio is successful in engineering the soil microbiome so that plants like corn could fixate nitrogen from the air, we could dramatically reduce the use of nitrogen fertilizer and the 3% of global greenhouse gases it generates today.

Around a century ago, the Haber-Bosch process revolutionized farming by allowing people to mass-produce nitrogen fertilizer. In our time, Leaps is working on the next revolution.

Two billion people in the world currently suffer from malnutrition and according to some estimates, we need 60% more food to feed the global population by 2050. Yet the agricultural sector is ill-equipped to meet this demand: 700 million of its workers currently live in poverty, and it is already responsible for 70% of the worlds water consumption and 30% of global greenhouse gas emissions.

New technologies could help our food systems become more sustainable and efficient, but unfortunately the agricultural sector has fallen behind other sectors in terms of technology adoption.

Launched in 2018, the Forums Innovation with a Purpose Platform is a large-scale partnership that facilitates the adoption of new technologies and other innovations to transform the way we produce, distribute and consume our food.

With research, increasing investments in new agriculture technologies and the integration of local and regional initiatives aimed at enhancing food security, the platform is working with over 50 partner institutions and 1,000 leaders around the world to leverage emerging technologies to make our food systems more sustainable, inclusive and efficient.

Learn more about Innovation with a Purpose's impact and contact us to see how you can get involved.

The societal value of innovation

Leaps by Bayer is our way of thinking big. I believe what we have learned can help restart a discussion about the value of new technologies in reaching the UN Sustainable Development Goals (SDGs) and transforming to a decarbonized economy. In my view, three points can help us harness these technological promises:

1. An honest discussion about risk-taking: "Who dares, wins" is an old saying, but its also the mindset we need. Im well aware that, especially in Europe, we are dealing with scepticism towards technological solutions. As societal acceptance is key, we should all engage in discussions about the value of innovation. This must include an honest exchange about cultural differences, the right regulatory framework and ways to ensure the responsible use of new technologies.

2. Companies and investors need to align their business models: In recent years, the binding force of the planetary boundaries has become scientifically obvious and the markets are reacting accordingly. At Bayer, we have aligned our business strategy with the SDGs. As a company and Leaps is a wonderful expression of that we thrive for what we believe is the ultimate goal of how to run a business: sustainable solutions and financial returns at the same time.

3. Nobody can do it alone: Our Leaps approach proves this rather general point. Its also a lesson that will remain from 2020. Dealing with the global health crisis and the scientific race to stop COVID-19 has encouraged unprecedented collaboration. Lets use this momentum for the greater good.

Read the original here:
Innovation in health and agriculture. We need to think bigger - World Economic Forum

Market trends and outlook coupled with factors driving and restraining the growth of the CRISPR Genome Editing market – The Daily Chronicle

Posted on by

With 75 percent of current S&P 500 companies expected to disappear until 2027, according to research by McKinsey. The only constant in our world is changing, the pace of change has been expediting significantly over the past years, fueled by huge investments in technology and science, easier access to truly global markets, and a general cultural shift towards innovation among other key drivers are helping to rise of CRISPR Genome Editing market.

This CRISPR Genome Editing research study presented by AMR aims at providing facts necessary to understand market dynamics and to capitalize on them, presenting the CRISPR Genome Editing research study with 118 number of pages and global key trends that can help clients in their CRISPR Genome Editing business to achieve more Goal, Desired Growth with making new business strategies to gain in the market.

Get a free sample and Benchmark your existing business against the market leader and identify fast-growing competitors at: https://www.amplemarketreports.com/sample-request/global-crispr-genome-editing-market-1635229.html

CRISPR Genome Editing Market Research study offers a comprehensive evaluation of the Market and comprises a future trend, current growth factors, focused opinions, details, and industry certified market data, sales, revenue, production and forecast and more.

CRISPR Genome Editing Market competitive landscape and Profile of Market Leaders

This market research study includes compiling intelligence data and structured and professional company profiles which will benefit to analyze competitors, a potential takeover target and Identifying leading market players across markets and find potential target markets.

Moreover, this market report provides in-depth analyses of CRISPR Genome Editing market and display significant data regarding key companies, consumers, market developments, and the competitive landscape focusing Editas Medicine, CRISPR Therapeutics, Horizon Discovery, Sigma-Aldrich, Genscript, Sangamo Biosciences, Lonza Group, Integrated DNA Technologies, New England Biolabs, Origene Technologies, Transposagen Biopharmaceuticals, Thermo Fisher Scientific, Caribou Biosciences, Precision Biosciences, Cellectis, Intellia Therapeutics.

CRISPR Genome Editing Market Segmentation by Product Type and Application

The CRISPR Genome Editing report focuses on consumers behaviors at a specific requirement by end-use, usage pattern providing more insights about its competitive landscape such as By Product Type(Genetic Engineering, Gene Library, Human Stem Cells) and Application(Biotechnology Companies, Pharmaceutical Companies).

Browse and Find out more on competitive landscape of CRISPR Genome Editing at: https://www.amplemarketreports.com/report/global-crispr-genome-editing-market-1635229.html

CRISPR Genome Editing Market Segmentation by Regions

This market research study presents dive deep into CRISPR Genome Editing and turn complex insights into ready-to-use analyses for you.

The research report is about the economic effects of the CRISPR Genome Editing market. This report reveals that there more economic benefits to North America, Europe, Asia Pacific (includes Asia & Oceania separately), the Middle East and Africa (MEA), and Latin America region, as well as other positive commercial and social effects.

Key Points Covered in CRISPR Genome Editing Market Report:

13.Current and historical revenues

Enquire more before buy at: https://www.amplemarketreports.com/enquiry-before-buy/global-crispr-genome-editing-market-1635229.html

Key Questions Answered in CRISPR Genome Editing Market Report:

AMR can provide all-round market research services for clients according to their requirements including Industry Research, Product market research, competitor research, channel research, and consumer research, etc. With evidence-based research methods, professional design, solid implementation, and professional research reports.

With the given market data, AMR offers customizations according to specific needs on Local, Regional and Global Markets.

Thanks for reading this article; you can also get individual chapter wise sections or region wise report versions like North America, LATAM, Europe or Southeast Asia or Just Eastern Asia.

About Author

Ample Market Research provides comprehensive market research services and solutions across various industry verticals and helps businesses perform exceptionally well. Our end goal is to provide quality market research and consulting services to customers and add maximum value to businesses worldwide. We desire to deliver reports that have the perfect concoction of useful data. Our mission is to capture every aspect of the market and offer businesses a document that makes solid grounds for crucial decision making.

Contact Address:

William James

Media & Marketing Manager

Address: 3680 Wilshire Blvd, Ste P04 1387 Los Angeles, CA 90010

Call: +1 (530) 868 6979

Email: [emailprotected]

https://www.amplemarketreports.com

Read the original here:
Market trends and outlook coupled with factors driving and restraining the growth of the CRISPR Genome Editing market - The Daily Chronicle

Healthcare Nanotechnology Market 2020-2026 to Post a CAGR of XX% Consumer research, Analytical Research Report, Market Size & Growth, Business…

Posted on by

Healthcare Nanotechnology Market report would come handy to understand the competitors in the market and give an insight into sales, volumes, revenues in the Healthcare Nanotechnology Industry & will also assists in making strategic decisions. The report also helps to decide corporate product & marketing strategies. It reduces the risks involved in making decisions as well as strategies for companies and individuals interested in the Healthcare Nanotechnology industry. Both established and new players in Healthcare Nanotechnology industries can use the report to understand the Healthcare Nanotechnology market.

In Global Market, the Following Companies Are Covered:

Get a Sample Copy of the Report @ https://www.360marketupdates.com/enquiry/request-sample/14865209

Analysis of the Market:

It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 100 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.

Nanotechnology is becoming a crucial driving force behind innovation in medicine and healthcare, with a range of advances including nanoscale therapeutics, biosensors, implantable devices, drug delivery systems, and imaging technologies.

Market Analysis and Insights: Global Healthcare Nanotechnology Market

In 2019, the global Healthcare Nanotechnology market size was USUSD 194920 million and it is expected to reach USUSD 372870 million by the end of 2026, with a CAGR of 9.6% during 2021-2026.

Global Healthcare Nanotechnology Scope and Market Size

Healthcare Nanotechnology market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Healthcare Nanotechnology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Healthcare Nanotechnology market is segmented into Nanomedicine, Nano Medical Devices, Nano Diagnosis, Others, etc.

Segment by Application, the Healthcare Nanotechnology market is segmented into Anticancer, CNS Product, Anti-infective, Others, etc.

Regional and Country-level Analysis

The Healthcare Nanotechnology market is analysed and market size information is provided by regions (countries).

The key regions covered in the Healthcare Nanotechnology market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape and Healthcare Nanotechnology Market Share Analysis

Healthcare Nanotechnology market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Healthcare Nanotechnology business, the date to enter into the Healthcare Nanotechnology market, Healthcare Nanotechnology product introduction, recent developments, etc.

The major vendors include Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen, Stryker, Gilead Sciences, Pfizer, 3M Company, Johnson & Johnson, Smith & Nephew, Leadiant Biosciences, Kyowa Hakko Kirin, Takeda, Ipsen, Endo International, etc.

This report focuses on the global Healthcare Nanotechnology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Healthcare Nanotechnology development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

Healthcare Nanotechnology Market Breakdown by Types:

s

Healthcare Nanotechnology Market Breakdown by Application:

Critical highlights covered in the Global Healthcare Nanotechnology market include:

The information available in the Healthcare Nanotechnology Market report is segmented for proper understanding. The Table of contents contains Market outline, Market characteristics, Market segmentation analysis, Market sizing, customer landscape & Regional landscape. For further improving the understand ability various exhibits (Tabular Data & Pie Charts) has also been used in the Healthcare Nanotechnology Market report.

Get a Sample Copy of the Report @ https://www.360marketupdates.com/enquiry/request-sample/14865209

Reasons for Buy Healthcare Nanotechnology Market Report:

In the end, Healthcare Nanotechnology Industry report provides the main region, market conditions with the product price,profit, capacity, production, supply, demand and market growth rateand forecast etc. This report also Present newproject SWOT analysis,investment feasibility analysis, andinvestment return analysis.

Contact Us:

Name: Mr. Ajay More

Email: [emailprotected]

Organization: 360 Market Updates

Phone: +14242530807 / + 44 20 3239 8187

Global Light Detection and Ranging (LIDAR) Market 2020 Industry Analysis, Size, Share, Trends, Market Demand, Growth, Opportunities and Showing Impressive Growth by 2026

Protein Expression Systems Market 2020 Growth Analysis, Share, and consumption by Regional data, Investigation and Growth, Demand by Regions, Types and Analysis of Key Players- Research Forecasts To 2026

Memory Modules Market 2020 with COVID-19 impact on Industry: Growth Global Industry Size, Top Countries Analysis & Topmanufacturers, Share, Market Demand, Growth, Opportunities and Forecast 2026

Urethral Bulking System Market 2020 Segmentation and Analysis by Recent Trends, Top Countries Analysis & Topmanufacturers, and consumption by Regional data, and Growth by to 2026

Heterojunction Bipolar Transistor Market Size in 2020 Industry Demand, Market Share, Trend, Industry News, Business Growth, Top Countries Analysis & Topmanufacturers, Top Key Players Update 2026

Originally posted here:
Healthcare Nanotechnology Market 2020-2026 to Post a CAGR of XX% Consumer research, Analytical Research Report, Market Size & Growth, Business...

Global Nanotechnology Market Expected to Reach highest CAGR: Nanosys, Inc., Nanophase Technologies Corporation, Altair Nanotechnologies Inc.,…

Posted on by

Global Nanotechnology Market: An Evaluation of the Scope

The above-mentioned Nanotechnology market report presentation has been gauged at length and according to expert analysis, is anticipated to entail an impressive growth of xx million USD in 2020 and is projected to further reach a total growth estimation of xx million USD through the forecast span until 2027, growing at a CAGR of xx%.

For supreme reader ease, this intricate research presentation on the global Nanotechnology market recognizes 2019 as the base year and 2020-27 establishes the overall forecast timeline, allowing detailed market approximation about growth likelihood in the Nanotechnology market.

Global Nanotechnology Market Dynamics Drivers: A systematic estimation of the major growth propellants prevalent across regional and global parlance. Barriers: This section of the report further includes a detailed analytical assessment of the major challenges faced by the market players besides also offering a probability review. Opportunities: Briefly addressing multiple consumption and production advances, competition concentration as well as growth tendencies observed across regional and global levels alike.

Vendor Landscape

Nanosys, Inc. Nanophase Technologies Corporation Altair Nanotechnologies Inc. ZyvexCorporation Acusphere, Inc. Bruker Nano GmbH Unidym, Inc. (subsidiary of WisePower Co.) Ablynx Advanced Diamond Technologies, Inc. SouthWestNanoTechnologies, Inc. PEN, Inc

Available Sample Report in PDF Version along with Graphs and [emailprotected] https://www.orbismarketreports.com/sample-request/121236?utm_source=PujaM

What To Expect From The Report A thorough study of dynamic segmentation of the Nanotechnology market. A complete analysis of the Nanotechnology market. A holistic review of the vital market alterations and developments. Concrete and tangible alterations in market dynamics. Notable growth friendly activities of leading players. A complete review of historical, current as well as potential foreseeable growth projections concerning volume and value.

Segment Assessment: Global Nanotechnology MarketIn this dedicated section of the report, readers are presented with decisive clarity towards highlighting the most effective segment that enables heavy revenue flow. Relevant details about other market segments are also discussed in the report to derive logical conclusions about the most prominent segments in global Nanotechnology market.

The market is broadly classified into: Segmentation by Type

NanomaterialsNanotoolsNanodevices

Segmentation by Application

Energy Biomedical Cosmetics Food Agriculture Defense Other

A birds eye view of other core facets such as vendor profiling, identification of local suppliers and manufacturers, eminent business houses and popular business strategies, besides prominent growth hubs that collectively result in lucrative returns in the global Nanotechnology market.

Read complete report along with TOC @ https://www.orbismarketreports.com/global-nanotechnology-market-analysis-by-growth-and-forecast-2025?utm_source=PujaM

COVID-19 Impact AnalysisThis intensively researched report presentation has been prepared in real time parlance, rendering substantial attention towards COVID-19 outbreak that has lately wreaked unprecedented damage across industries, stagnating growth.

Regional Overview: Global Nanotechnology Market The report also sheds a versatile understanding on market overview, stating pertinent details on leading market participants, including details on upstream and downstream market developments. Inputs on crucial areas such as dominant trends, upstream and downstream developments inclusive of vital details such as product and services extensions, portfolio diversification form prudent parameters. Further, the report also lends its readers with an immense understanding on various stakeholder developments, new segment expansions, opportunity scavenging that collectively enable a thumping growth in the global Nanotechnology market. A rundown across multiple market growth catalysts that influence sustainability and growth in the global Nanotechnology market. An assessment of budding opportunities as well as growth hotspots across regions and countries alike A systematic guide of the various marketing strategies adopted by market players in the interest of market expansion and growth sustainability.

Regional and Country-wise Analysis: Global Nanotechnology Market North America (U.S., Canada, Mexico) Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS) Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific) Latin America (Brazil, Rest of L.A.) The Middle East and Africa (Turkey, GCC, Rest of Middle East)

The market has been thoroughly studied and analysis of the current economic scenarios has also been entailed to aid business planning of the new market entrants besides core investment decisions across emerging countries.

Some Major TOC Points: Chapter 1. Report Overview Chapter 2. Global Growth Trends Chapter 3. Market Share by Key Players Chapter 4. Breakdown Data by Type and Application Chapter 5. Market by End Users/Application Chapter 6. COVID-19 Outbreak: Nanotechnology Industry Impact Chapter 7. Opportunity Analysis in Covid-19 Crisis Chapter 9. Market Driving ForceAnd Many More

Besides an in-depth analysis of the leading players, this section of the report also includes relevant details about certain market drivers and growth factors. The report, therefore, gives a tour of the thriving market scenario, demand and supply analysis, technological milestones.

Ask For Discount:@ https://www.orbismarketreports.com/discount/121236?utm_source=PujaM

Market Report Offerings in a Gist: A thorough reference of the dominant trends as well as relevant market dynamics Elaborate analysis and reference of core products and dynamic segments A thorough analysis of the competition spectrum and winning strategies of the major players COVID-19 analysis and recovery route PESTEL and SWOT analysis besides other analysis

About Us :

We are a team of highly professional researchers dedicated to unravel ongoing market developments. We are recognized as best in industry one stop store, offering intensively researched market-oriented information with superlative standards of impartiality and authenticity in order to rightfully influence favorable business decisions across a range of verticals. We are highly dependent on our information scavenging abilities and extremely reliant on our intuitive capabilities that lead towards novel opportunity mapping and result in profitable business models and high revenue structures.

Contact Us :

Hector CostelloSenior Manager Client Engagements4144N Central Expressway,Suite 600, Dallas,Texas 75204, U.S.A.Phone No.: USA: +1 (972)-362-8199 | IND: +91 895 659 5155

Go here to read the rest:
Global Nanotechnology Market Expected to Reach highest CAGR: Nanosys, Inc., Nanophase Technologies Corporation, Altair Nanotechnologies Inc.,...

Healthcare Nanotechnology Market: Opportunities, Demand and Forecasts, 2020 – News by aeresearch

Posted on by

Global Covid-19 Impact on Healthcare Nanotechnology market study presents an in-depth scenario Which is segmented according to manufacturers, product type, applications, and areas. This segmentation will provide deep-dive analysis of the Covid-19 Impact on Healthcare Nanotechnology industry for identifying the growth opportunities, development trends and factors limiting the growth of the market. This report offers forecast market information based on previous and current Covid-19 Impact on Healthcare Nanotechnology industry scenarios and growth facets.

The latest report on the Healthcare Nanotechnology market entails latest industry data and projections backed by historical statistics and growth opportunities over the study period. In addition, the report comments on the impact of COVID-19 pandemic on this business sphere.

The report studies in complete details the multiple segmentations, inclusive of the product terrain, application spectrum, and regional territories. Key trends that will influence growth of each segment in the forthcoming years are factored in the report to impart a deeper understanding. Apart from this, a pool of leading players is assessed in the study to decipher the competitive dynamics of this industry vertical.

Request Sample Copy of this Report @ https://www.aeresearch.net/request-sample/306660

Main highlights from the Healthcare Nanotechnology market report:

Geographical landscape of the Healthcare Nanotechnology market:

Healthcare Nanotechnology market segmentation: Americas, APAC, Europe, Middle East & Africa.

A gist of the regional analysis:

Product types and application spectrum of the Healthcare Nanotechnology market:

Product landscape:

Types: Nanomedicine, Nano Medical Devices, Nano Diagnosis, Others, Nanomedicine has the highest percentage of revenue by type and with more than 86% in 2019

Main highlights listed in the report:

Application spectrum:

Application scope: Anticancer, CNS Product, Anti-infective, Others, According to the application and anticancer and CNS products accounted for 17.56% and 22.70% of the market in 2019 respectively

Specifics mentioned in the document:

Competitive outlook of the Healthcare Nanotechnology market:

Companies profiled in the study: Amgen, Stryker, Teva Pharmaceuticals, UCB, Roche, Abbott, Merck & Co, Celgene, Biogen, Sanofi, Leadiant Biosciences, Shire, Kyowa Hakko Kirin, Gilead Sciences, Johnson & Johnson, 3M Company, Endo International, Smith & Nephew, Pfizer and Ipsen

Key pointers from the report:

The Healthcare Nanotechnology Market Report Addresses the Following Queries:

Request Customization on This Report @ https://www.aeresearch.net/request-for-customization/306660

See original here:
Healthcare Nanotechnology Market: Opportunities, Demand and Forecasts, 2020 - News by aeresearch

Global Nanotechnology and Nanomaterials Market 2020 One the most booming industry in forthcoming years due to worldwide demand in Coronavirus…

Posted on by

Global Nanotechnology and Nanomaterials Market Analysis Providing Latest Market Trends And Developments

TheNanotechnology and Nanomaterials Marketreport is a compilation of market analysis, qualitative & quantitative industry analysis, and import & export study. Furthermore, the research report also provides an in-depth analysis of the key market trends, economic status, growth drivers, and market strategies for the better understanding of the third party. The report is made attractive through the immense data being offered through each and every segment. The qualitative impact of the market opportunities and restraints on every segment and region is also mapped in a precise manner.

Get Exclusive PDF Sample Copy Of This Report@https://www.marketdataanalytics.biz/global-nanotechnology-and-nanomaterials-market-industry-trends-and-forecast-29198.html#request-sample

The Nanotechnology and Nanomaterials market report provides all the precisely studied and assessed data of the key market players and their scope in the industry. Some of the key market players includeBASF SE, Minerals Technologies Inc, Liquidia Technologies, NanoOpto, Frontier Carbon Corporation, Hosokawa Micron Group, Hyperion Catalysis International Incorporated, Nanophase Technologies Corporation, BBI Solutions, Cline Scientific, Cytodiagnostics, Goldsol, Meliorum Technologies, nanoComposix, Sigma Aldrich, Tanaka Technologies, Innova Biosciences. There is an elaborate explanation about the key strategic developments of the market, regional growth of the key players, product launches, and other factors in the report. Other key market growth indicators such as gross margin, share & revenue, supply & demand, and production rate are also mentioned in the Nanotechnology and Nanomaterials market research report.In addition, the study incorporates a comprehensive study of the major market dynamics and their latest trends, along with appropriate market segments and sub-segments.

Product Type analysis:CarbonNanotubes, Nanoclays, Nanofibers, Nanosilver, Others

Application analysis:Aerospace, Automotive, Medical, Military, Electronics

Similarly, the regional players North America (U.S., Canada, Mexico), South America (Cuba, Brazil, Argentina, and many others.), Europe (Germany, U.K., France, Italy, Russia, Spain, etc.), Asia (China, India, Russia, and many other Asian nations.), Pacific region (Indonesia, Japan, and many other Pacific nations.), Middle East & Africa (Saudi Arabia, South Africa, and many others.) also aids in understanding the market position on the global and regional platform.

Complete report information along with sample/table of contents available::https://www.marketdataanalytics.biz/global-nanotechnology-and-nanomaterials-market-industry-trends-and-forecast-29198.html

Major points of the Nanotechnology and Nanomaterials market report:

Complete assessment of all opportunities and challenges in the Nanotechnology and Nanomaterials market Nanotechnology and Nanomaterials market present developments and future trends Comprehensive study of trade strategies for growth of the Nanotechnology and Nanomaterials key market players Detailed study of the market growth factors for the forthcoming years In-depth understanding of Nanotechnology and Nanomaterials market drivers, challenges, and key micro markets. Favorable factors inside dynamic technological and market latest trends striking the Nanotechnology and Nanomaterials market

This report can be customized as per your needs for additional data. The Nanotechnology and Nanomaterials market research report provides the statistical forecasts, detailed segmentation, competitive landscape, key trends, and strategic recommendations, thereby providing a 360 degree view of the market.

Place Inquiry for Buying or Customization of Report:https://www.marketdataanalytics.biz/global-nanotechnology-and-nanomaterials-market-industry-trends-and-forecast-29198.html#inquiry-for-buying

About Us

Market Data Analytics is a leading global market research and consulting firm. We focus on business consulting, industrial chain research, and consumer research to help customers provide non-linear revenue models. We believe that quality is the soul of the business and that is why we always strive for high quality products. Over the years, with our efforts and support from customers, we have collected inventive design methods in various high-quality market research and research teams with extensive experience.

Read more:
Global Nanotechnology and Nanomaterials Market 2020 One the most booming industry in forthcoming years due to worldwide demand in Coronavirus...

Are You Gassy And Bloated? – Anti Aging News

Posted on by

Is your tummy making loud noises, maybe you are too full to move around, pants feel too tight, feels like a hardball in your midsection, whatever symptom you are experiencing being gassy and bloated is not a good feeling.

While there is no denying that diet contributes to gut health, there are still many potential causes of uncomfortable gastrointestinal symptoms. Typically when experienced after eating it most likely due to byproducts that are created by bacteria in the GI Tract to help break down food because eating increases the water content in the gut and drawing in fluids can make one feel bloated.

"In general, diet is probably the main driver of a lot of GI symptoms," says Shanti Eswaran, MD, a gastroenterologist and internist at Michigan Medicine. "What we eat moves through our body and undergoes transformations as it's broken down by enzymes and bacteria in the GI tract."

According to Eswaran the primary cause of gas and bloating is IBS which can be caused by a range of things with the hallmarks being abdominal pain, discomfort, and altered bowel function including constipation and diarrhea. Those with IBS tend to experience increased pain or bloating after eating.

To help avoid experiencing gas and bloating try to eat smaller meals throughout the day and avoid carbonated beverages. Vitamin D deficiencies are prevalent among those with IBS, but this nutrient deficiency is not unique to this population of people.

"The majority of adults living in certain geographies or who lead indoor lifestyles tend to have low vitamin D levels and they are generally related to lack of sun exposure, though obesity is another risk factor," says Tamara Duker Freuman, RDN.

A report published in the International Journal of Preventive Medicine suggests that vitamin D supplementation helps to significantly improve the severity of symptoms and disease-specific quality of life for those with IBS compared to those without.

But according to Eswaran supplementation on its own may not solve all gut-specific symptoms. "However, it may improve general symptoms associated with vitamin D deficiency such as brain fog and fatigue, and if you're feeling well overall, it's possible that your GI symptoms may not bother you as much."

In addition to supplementation, one can naturally obtain vitamin D by spending some time in the sun, in some foods such as egg yolk, mushrooms, fatty fish, and fortified foods.

Fibre may or may not be beneficial for those that experience gas and bloating, for some a high fibre diet can induce or exacerbate gas and bloating while for others a low fibre diet can do the same thing. To add to that high intake of fibre may lead to some experiencing these symptoms as the result of a high stool burden or more fibre going in than is going out which can cause stool to build up, and to add to the confusion a diet lacking in fibre can also result in tummy troubles.

"Everyone is different, and you have to evaluate each case of bloating individually to understand what's behind it," Freuman notes. "The same remedy that helps alleviate symptoms in one person can worsen symptoms in someone else.

"People with chronically low fiber intake can also experience intestinal gas or bloating if their low fiber intake results in chronic constipation and/or incomplete defecation of hard, small stools," adds Freuman.

"However, if someone is bloated due to constipation from a low fiber diet, the right answer is to add fiber very gradually, possibly in tandem with a gentle bowel regimen (or laxative) to help clear out residual stool that is causing a backup so that the fiber will be tolerated better," says Freuman.

To boost fibre intake while minimizing the risk of worsening gas and bloating try to eat fibre-containing foods that are lower in fermentable carbohydrates and have been texture modified to decrease fibre particle size such as smoothies and soups rather than salads, cooked veggies rather than raw, and nut butter rather than whole nuts which may be better tolerated for those who are prone to bloating from high fibre intake.

Fibre intake should be increased gradually by about 3-5 grams and staying at that level for several days before upping intake again to avoid discomfort. Also, be sure to increase your water intake as you add more fibre to your diet.

"Fiber and fluid should always be increased simultaneously," says Lauren Cornell, RDN. "Even if you have no intolerances to FODMAPs (most FODMAPs are a form of fiber), increasing your fiber intake without also increasing your fluid intake is bound to cause some gas or bloating."

If you continue to experience discomfort it might help to consult with a registered dietician who will work with you to identify your triggers and explore options to help with gas and bloating issues.

Link:
Are You Gassy And Bloated? - Anti Aging News

The Geographic Bias in Medical AI Tools – Stanford University News

Posted on by

Just a few decades ago, scientists didnt think much about diversity when studying new medications. Most clinical trials enrolled mainly white men living near urban research institutes, with the assumption that any findings would apply equally to the rest of the country. Later research demonstrated that assumption to be false; examples accumulated of medications that were later determined to be less effective or caused more side effects in populations that were underrepresented in the initial study.

To address these inequities, federal requirements for participation in medical research were broadened in the 1990s, and clinical trials now attempt to enroll diverse populations from the onset of the study.

But we are now at risk of repeating these same mistakes as we develop new technologies, such as AI. Researchers from Stanford University examined clinical applications of machine learning to find that most algorithms are trained on datasets from patients in only three geographic areas, and that the majority of states have no represented patients whatsoever.

AI algorithms should mirror the community, says Amit Kaushal, an attending physician at VA Palo Alto Hospital and Stanford adjunct professor of bioengineering. If were building AI-based tools for patients across the United States, as a field, we cant have the data to train these tools all coming from the same handful of places.

Kaushal, along with Russ Altman, a Stanford professor of bioengineering, genetics, medicine, and biomedical data science, and Curt Langlotz, a professor of radiology and biomedical informatics research, examined five years of peer-reviewed articles that trained a deep-learning algorithm for a diagnostic task intended to assist with patient care. Among U.S. studies where geographic origin could be characterized, they found the majority (71%) used patient data from California, Massachusetts, or New York to train the algorithms. Some 60% solely relied on these three locales. Thirty-four states were not represented at all, while the other 13 states contributed limited data.

The research didnt expose bad outcomes from AI trained on the geographies, but raised questions about the validity of the algorithms for patients in other areas. We need to understand the impact of these biases and whether considerable investments should be made to remove them, says Altman, associate director of the Stanford Institute for Human-Centered Artificial Intelligence.

Geography correlates to a zillion things relative to health, Altman says. It correlates to lifestyle and what you eat and the diet you are exposed to; it can correlate to weather exposure and other exposures depending on if you live in an area with fracking or high EPA levels of toxic chemicals all of that is correlated with geography.

If these datasets were used for an algorithm to diagnose patients across the United States, you could be doing actual harm to the people not included in the sample.

Limited data also means limited vision. The data you have available impacts the problems you can study in the first place, Kaushal says. If I only have access to data from California, Massachusetts, and New York, I can build algorithms to help people in those places. But problems that are more common in other geographies wont even be on my radar.

The takeaways from this study: Larger and more diverse datasets are needed for the development of innovative AI algorithms. Stanford has led the way in making diagnostic datasets freely available for science more than any other center by far, says Langlotz, director of the Stanford Center for Artificial Intelligence in Medicine and Imaging. But its expensive and its not enough. Resources are needed to help centers across the country contribute to more diverse training datasets.

The public also should be skeptical when medical AI systems are developed from narrow training datasets. And regulators must scrutinize the training methods for these new machine learning systems.

Medicine has been down this road before early clinical trials didnt think much about gender, racial, or geographic diversity and we are still working to address that oversight, Kaushal says. As AI is set to enter clinical medicine, we shouldnt have to wait 30, 40 years to make all the same mistakes and fix them again. We should see where this is headed and address it upfront.

Stanford HAI's mission is to advance AI research, education, policy and practice to improve the human condition.Learn more.

See more here:
The Geographic Bias in Medical AI Tools - Stanford University News

Chitosan Derivatives Market: Technological Advancement & Growth Analysis with Forecast to 2025 – The Daily Chronicle

Posted on by

Latest Research Report: Chitosan Derivatives industry

This has brought along several changes in This report also covers the impact of COVID-19 on the global market.

Global Chitosan Derivatives Market documents a detailed study of different aspects of the Global Market. It shows the steady growth in market in spite of the fluctuations and changing market trends. The report is based on certain important parameters.

Get a Sample PDF copy of the report @ https://reportsinsights.com/sample/12061

Chitosan Derivatives Market competition by top manufacturers as follow: , FMC Corp, Kitozyme, Kunpoong Bio, BIO21, Heppe Medical Chitosan, Yaizu Suisankagaku, Golden-Shell, Lushen Bioengineering, AK BIOTECH, Zhejiang New Fuda Ocean Biotech, Weifang Sea Source Biological Products, Qingdao Honghai Bio-tech, Haidebei Marine Bioengineering, Jiangsu Aoxin Biotechnology, Jinhu Crust Product

The risingtechnology in Chitosan Derivativesmarketis also depicted in thisresearchreport. Factors that are boosting the growth of the market, and giving a positive push to thrive in the global market is explained in detail. It includes a meticulous analysis of market trends, market shares and revenue growth patterns and the volume and value of the market. It is also based on a meticulously structured methodology. These methods help to analyze markets on the basis of thorough research and analysis.

The Type Coverage in the Market are: Chitosan HClCarboxymethyl ChitosanChitosan Quaternary Ammonium SaltHydroxypropyl ChitosanChitosan OligosaccharideOthers

Market Segment by Applications, covers:MedicalHealth FoodCosmeticsWater TreatmentOthers

The research report summarizes companies from different industries. This Chitosan Derivatives Market report has been combined with a variety of market segments such as applications, end users and sales. Focus on existing market analysis and future innovation to provide better insight into your business. This study includes sophisticated technology for the market and diverse perspectives of various industry professionals.

Chitosan Derivatives is the arena of accounting worried with the summary, analysis and reporting of financial dealings pertaining to a business. This includes the training of financial statements available for public ingesting. The service involves brief, studying, checking and reporting of the financial contacts to tax collection activities and objects. It also involves checking and making financial declarations, scheming accounting systems, emerging finances and accounting advisory.

To get this report at a profitable rate.: https://reportsinsights.com/discount/12061

Market segment by Regions/Countries, this report coversNorth AmericaEuropeChinaRest of Asia PacificCentral & South AmericaMiddle East & Africa

Report Highlights: Detailed overview of parent market Changing market dynamics in the industry In-depth market segmentation Historical, current and projected market size in terms of volume and value Recent industry trends and developments Competitive landscape Strategies of key players and products offered Potential and niche segments, geographical regions exhibiting promising growth A neutral perspective on market performance Must-have information for market players to sustain and enhance their market footprint

Access full Report Description, TOC, Table of Figure, Chart, [emailprotected] https://reportsinsights.com/industry-forecast/Chitosan-Derivatives-Market-12061

About US:

Reports Insights is the leading research industry that offers contextual and data-centric research services to its customers across the globe. The firm assists its clients to strategize business policies and accomplish sustainable growth in their respective market domain. The industry provides consulting services, syndicated research reports, and customized research reports.

Contact US:

:(US) +1-214-272-0234

:(APAC) +91-7972263819

Email:[emailprotected]

Sales:[emailprotected]

See more here:
Chitosan Derivatives Market: Technological Advancement & Growth Analysis with Forecast to 2025 - The Daily Chronicle

Wearable Physical Capacity Evaluation System Market 2020 Industry Analysis,Trends and Forecast 2026:Hocoma, Am Cube, MIE Medical Research, LiteGait,…

Posted on by

Global Wearable Physical Capacity Evaluation System market research report accurately portrays a well-conceived and elaborate scenario with references to various facets and elements of the market that result in uncompromised growth trajectory.The report draws special references to elements such as product and application segments, regional expanse as well as manufacturing activities, with elaborate cues on dominant trends, persistent challenges as well as untapped market opportunities that systematically lead to uncompromised growth and sustenance in global Wearable Physical Capacity Evaluation System market.This market report is a thoroughly researched analytical review of the current market scenario that directly affect onward growth trajectory of the Wearable Physical Capacity Evaluation System market. The report is a single stop solution aimed at offering actionable insights to adequately influence an unperturbed growth trail in the aforementioned discussed market.

Get Sample Copy of this Report to understand the structure of the complete report: https://www.orbispharmareports.com/sample-request/51912

This systematically compiled research output based on elaborate primary and secondary research practices also shed light on the ongoing implications of COVID-19 that has resulted in lopsided growth in the global Wearable Physical Capacity Evaluation System market through the forecast span.The report is customized section on the back of relentless research and analysis expertise that align with market players objectives to remain profit oriented despite unfavorable market forces that have significantly halted growth and development with pandemic crisis.

Major Company Profiles operating in the Wearable Physical Capacity Evaluation System Market:

HocomaAm CubeMIE Medical ResearchLiteGaitBioMed JenaBTS BioengineeringGaitUpTekscan, Inc.Techno ConceptNovel DEMediTouchExelH/p/cosmosReTiSenseSensor Medica

Read complete report along with TOC @ https://www.orbispharmareports.com/covid-19-impact-on-global-wearable-physical-capacity-evaluation-system-industry-research-report-2020-segmented-by-major-market-players-types-applications-and-countries-forecast-to-2026-2/

Orbis Pharma Reports is a dedicated, best in industry one stop store, offering intensively researched market-oriented information with superlative standards of impartiality and authenticity in order to rightfully influence favorable business decisions across a range of verticals, inclusive of pharmaceutical and healthcare industries. We are highly dependent on our information scavenging abilities and extremely reliant on our intuitive capabilities that lead towards novel opportunity mapping and result in profitable business models and high revenue structures. At Orbis Pharma Reports we categorically offer expert market research-oriented services across a heterogenous range of industrial participants, such as manufacturing companies, corporations, product development companies, who stand in greater need of market specific information.This intricately devised market research protocols encourage ours research experts and analysts to traverse the extra mile towards information procurement, thus enabling us to become requisite research partners and knowledge scavengers to optimally source multidimensional information for superlative market understanding.

By the product type, the market is primarily split into

Posture Analysis SystemGaint Analysis SystemOther

By the application, this report covers the following segments

HospitalClinicRehabilitation CentreOther

TOC Brief: Global Wearable Physical Capacity Evaluation System MarketSection I: Introduction and Market DefinitionSection II: Research MethodologySection III: Executive SummarySection IV: Overview & Highlights on Porters Five Force Analysis, Supply-chain Updates, Threat Analysis of Competitive SubstitutesSection V: Market Dynamics Including DROT OverviewSection VI: Systematic Segmentation of Type, Application and End-UserSection VII: Geographical DiversificationSection VIII: Brief on Premier Competitors, Highlighting M&A, Business Collaborations, Product LaunchSection IX: Key Player Profile

Make an enquiry of this report @ https://www.orbispharmareports.com/enquiry-before-buying/51912

About Us :

At Orbispharma we curate the most relevant news stories, features, analysis and research reports on the important challenges undertaken by the pharmaceutical and related sectors. Our editorial philosophy is to bring you sharp, focused and informed perspective of industries, the end users and application of all upcoming trends into the pharma sector. Orbispharma believes in conversations that can bring a change in one of the most crucial economic sectors in the world. With these conversations we wish our customers to make sound business decisions with right business intelligence.

Contact Us :

See more here:
Wearable Physical Capacity Evaluation System Market 2020 Industry Analysis,Trends and Forecast 2026:Hocoma, Am Cube, MIE Medical Research, LiteGait,...

NIH Awards Health Tech Companies with Grants to Develop COVID-19 Apps and Solutions – BioSpace

Posted on by

The U.S. National Institutes of Health (NIH) awarded seven companies and academic institutions grants to develop digital health technology to help with the COVID-19 pandemic. These technologies include things such as smartphone apps, wearable devices and software. The winners were:

Evidation Health. Based in San Mateo, California, Evidation will work on developing a health measurement platform that can analyze a variety of patient-consented data to detect COVID-19 and differentiate it from influenza.

IBM. Headquartered in Armonk, New York, IBMs integrated solution will support contact tracing and verifiable health status reporting.

iCrypto. Located in Santa Clara, California, iCrypto is developing a smartphone-based platform to provide irrefutable proof of testing, serologic and vaccination status for individuals.

physIQ. Based in Chicago, physIQ is working on an artificial intelligence (AI)-based data analytics and cloud computing platform with U.S. Food and Drug Administration (FDA)-cleared wearable devices. The goal is to create a personalized baseline index that would indicate a change in health status for people who tested positive for COVID-19.

Shee Atika Enterprise. Located in Sitka, Alaska, Shee Atika is developing a smartphone-based platform to monitor and support individuals with COVID-19 symptoms who may need testing and those who have tested positive already. It will integrate a Bluetooth-enabled thermometer and pulse oximeter.

University of California, San Francisco. UCSF is working on a GPS-based retroactive contact-tracing tool to alert users about contact with COVID-19-positive people and identifying businesses that were visited by people that later tested positive.

Vibrent Health. Headquartered in Fairfax, Virginia, Vibrent is developing mobile apps, data integrations, and validated machine learning algorithms to identify COVID-19 and differentiate it from influenza and to perform contact tracing leveraging Wi-Fi technology.

The National Institute of Biomedical Imaging and Bioengineering (NIBIB) also awarded a separate contract to CareEvolution, based in Ann Arbor, Michigan, for SAFER-COVID, a digital health solution that integrates self-reported symptoms, collects data from consumer wearables, electronic health record and data claims, and COVID-19 test results.

The tools these organizations plan to develop could allow us to use containment efforts, like COVID-19 testing, social distancing, and quarantine, precisely when and where theyre needed, stated NCI Director Norman E. Ned Sharpless. That might let more people return to less restricted living and reduce the risk of devastating local outbreaks. We are working as quickly as possible to help businesses and universities develop innovative tools to achieve this goal.

The seven projects were chosen from 200 different proposals by the National Cancer Institute (NCI) and NIBIB, both part of NIH. The awards are part of the two organizations congressionally supported responses to COVID-19, and include NCIs $306 million effort to support serological science research, expand the U.S. testing capacity for COVID-19, and develop other technologies.

The contracts will be granted in two phases. The initial awards for phase one will be to demonstrate each projects feasibility. After phase one is evaluated, phase two offers a contractual option that would provide more funding for further development. If all seven projects move into the second phase, the total contracts would be worth $22.8 million. All recipients have one year to complete both phases.

Despite the technology advances and attention paid to COVID-19, the healthcare community is still monitoring patient vitals the very same way as we did in the 1800s, said Steven Steinhubl, director of Digital Medicine at Scripps Translational Science Institute (STSI) and an advisor to physIQ. With the advances in digital technology, AI and wearable biosensors, we can deliver personalized medicine remotely giving caregivers new tools to proactively address this pandemic. For that reason alone, this decision by the NIH has the potential to have a monumental impact on our healthcare system and how we manage COVID-19 patients.

Read the rest here:
NIH Awards Health Tech Companies with Grants to Develop COVID-19 Apps and Solutions - BioSpace

Impact of Corona on Fumaric Acid Market : What is the expected CAGR? – The Daily Chronicle

Posted on by

The globalFumaric Acid Marketis carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Fumaric Acid market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global Fumaric Acid market. With qualitative and quantitative analysis, we help you with thorough and comprehensive research on the global Fumaric Acid market. We have also focused on SWOT, PESTLE, and Porters Five Forces analyses of the global Fumaric Acid market.

Leading players of the global Fumaric Acid market are analyzed taking into account their market share, recent developments, new product launches, partnerships, mergers or acquisitions, and markets served. We also provide an exhaustive analysis of their product portfolios to explore the products and applications they concentrate on when operating in the global Fumaric Acid market. Furthermore, the report offers two separate market forecasts one for the production side and another for the consumption side of the global Fumaric Acid market. It also provides useful recommendations for new as well as established players of the global Fumaric Acid market.

To know How COVID-19 Pandemic Will Impact This Market/Industry -Request sample copy of this report:https://www.reporthive.com/request_sample/2407875

Major Players:

Yantai Hengyuan BioengineeringChangzhou Yabang ChemicalThirumalai ChemicalBartek IngredientsJiangsu Jiecheng BioengineeringPolyntSealong BiotechnologyFuso ChemicalsIsegenNIPPON SHOKUBAIChangmao Biochemical EngineeringSuzhou Youhe Science and TechnologyXST Biological

Segmentation by Product:

Food-GradeTechnical-Grade

Segmentation by Application:

Food & BeveragesRosin Paper SizesUnsaturated Polyester ResinAlkyd ResinsOthers

Regions and Countries:U.S, Canada, France, Germany, UK, Italy, Rest of Europe, India, China, Japan, Singapore, South Korea, Australia, Rest of APAC, Brazil, Mexico, Argentina, Rest of LATAM, Saudi Arabia, South Africa, UAE.

Report Objectives

For More Information or Query or Customization Before Buying, Visit at -:https://www.reporthive.com/request_customization/2407875

Table of Contents

Report Overview:It includes major players of the global Fumaric Acid market covered in the research study, research scope, and Market segments by type, market segments by application, years considered for the research study, and objectives of the report.

Global Growth Trends:This section focuses on industry trends where market drivers and top market trends are shed light upon. It also provides growth rates of key producers operating in the global Fumaric Acid market. Furthermore, it offers production and capacity analysis where marketing pricing trends, capacity, production, and production value of the global Fumaric Acid market are discussed.

Market Share by Manufacturers:Here, the report provides details about revenue by manufacturers, production and capacity by manufacturers, price by manufacturers, expansion plans, mergers and acquisitions, and products, market entry dates, distribution, and market areas of key manufacturers.

Market Size by Type:This section concentrates on product type segments where production value market share, price, and production market share by product type are discussed.

Market Size by Application:Besides an overview of the global Fumaric Acid market by application, it gives a study on the consumption in the global Fumaric Acid market by application.

Production by Region:Here, the production value growth rate, production growth rate, import and export, and key players of each regional market are provided.

Consumption by Region:This section provides information on the consumption in each regional market studied in the report. The consumption is discussed on the basis of country, application, and product type.

Company Profiles:Almost all leading players of the global Fumaric Acid market are profiled in this section. The analysts have provided information about their recent developments in the global Fumaric Acid market, products, revenue, production, business, and company.

Market Forecast by Production:The production and production value forecasts included in this section are for the global Fumaric Acid market as well as for key regional markets.

Market Forecast by Consumption:The consumption and consumption value forecasts included in this section are for the global Fumaric Acid market as well as for key regional markets.

Value Chain and Sales Analysis:It deeply analyzes customers, distributors, sales channels, and value chain of the global Fumaric Acid market.

Key Findings:This section gives a quick look at important findings of the research study.

About us:

Our research base consists of a wide spectrum of premium market research reports. Apart from comprehensive syndicated research reports, our in-house team of research analysts leverages excellent research capabilities to deliver highly customized tailor-made reports. The market entry strategies presented in our reports has helped organizations of all sizes to generate profits by making timely business decisions. The research information including market size, sales, revenue, and competitive analysis offered, is the product of our excellence in the market research domain.

Go here to see the original:
Impact of Corona on Fumaric Acid Market : What is the expected CAGR? - The Daily Chronicle

AI-Based Digital Biomarker Could Assist in Early Intervention in High-Risk COVID-19 Patients – HospiMedica

Posted on by

Image: AI-Based Digital Biomarker Could Assist in Early Intervention in High-Risk COVID-19 Patients (Photo courtesy of Business Wire)

The National Cancer Institute (NCI) and the National Institute of Biomedical Imaging and Bioengineering (NIBIB) of the National Institutes of Health (NIH Bethesda, MA, USA) have awarded a contract to PhysIQ (Chicago, IL, USA) to develop an AI-based COVID-19 Decompensation Index (CDI) Digital Biomarker to address the rapid decline of high-risk COVID-19 patients. The new early warning system under development could allow providers to intervene sooner when a COVID-19 patient is clinically surveilled from home and begins to worsen. Rather than relying on point measurements, such as temperature and SpO2, that are known to be lagging or insensitive indicators of COVID-19 decompensation, continuous multi-parameter vital signs will be used to establish a targeted biomarker for COVID-19.

PhysIQ will develop and validate a CDI algorithm that builds off existing wearable biosensor-derived analytics generated by physIQs pinpointIQ end-to-end cloud platform for continuous monitoring of physiology. The data will be gathered through a clinical study of COVID-19 positive patients and build upon work already in-place for monitoring COVID-19 patients convalescing at home. For patients who participate in the program, physiological data will be collected before and after their admission to the hospital.

In the development phase of this project, physIQ and its clinical partner will monitor participants who are confirmed COVID-19 positive, whether recovering at home or following a discharge from the hospital. During the validation phase, physIQ will evaluate lead time to event statistics, decompensation severity assessments, and the ability for CDI to predict decompensation severity. The study is designed to capture data from a large, diverse population to investigate CDI performance differences among subgroups based on sex/gender and racial/ethnic characteristics. The project will not only enable the development and validation of the CDI, but also collect rich clinical data correlative with outcomes and symptomology related to COVID-19 infection. The index will build on physIQs prior FDA-cleared, AI-based multivariate change index (MCI) that has amassed more than 1.5 million hours of physiologic data, supporting development of this targeted digital biomarker for COVID-19.

Despite the technological advances and attention paid to COVID-19, the healthcare community is still monitoring patient vitals the very same way as we did in the 1800s, said Steven Steinhubl MD, Director of Digital Medicine at Scripps Translational Science Institute (STSI) and a physIQ advisor. With the advances in digital technology, AI and wearable biosensors, we can deliver personalized medicine remotely giving caregivers new tools to proactively address this pandemic. For that reason alone, this decision by the NIH has the potential to have a monumental impact on our healthcare system and how we manage COVID-19 patients.

Related Links:The National Institutes of Health (NIH)PhysIQ

See the original post here:
AI-Based Digital Biomarker Could Assist in Early Intervention in High-Risk COVID-19 Patients - HospiMedica

NIH to fund 7 digital health projects aimed at COVID-19 – FierceBiotech

Posted on by

The National Institutes of Health has picked seven companies and academic centers to help develop digital health solutions aimed at the COVID-19 pandemicincluding smartphone apps, wearables and big data programs to mitigate the personal and public health impacts of the novel coronavirus.

Each one-year contract includes two phases: an initial award for feasibility testing, followed by an option for additional development funding. If all seven progress to the second phase, the total value of awards would reach $22.8 million.

The selected projects include an effort by IBM to provide sophisticated digital contact tracing, alongside verifiable methods for reporting a persons health status following exposure and testing.

Join the world's top medtech executives virtually for the leading event in medtech The Virtual MedTech Conference by AdvaMed

Expect the same high-quality education, world-class speakers and valuable business development in a virtual format. Experience more of the conference with on demand content and partnering, as well as livestreamed sessions.

Meanwhile, Evidation Health has proposed an artificial intelligence-powered early warning system for COVID-19, which would take in a wide range of patient data from questionnaires and wearable devices and potentially differentiate cases from the flu.

The tools these organizations plan to develop could allow us to use containment efforts, like COVID-19 testing, social distancing and quarantine, precisely when and where theyre needed, said Ned Sharpless, director of the NIHs National Cancer Institute, which helped select the seven winners from nearly 200 submissions. That might let more people return to less restricted living and reduce the risk of devastating local outbreaks.

RELATED: The quest for a COVID-19 digital warning system taps smartwatches, rings and more

iCrypto was chosen for its smartphone-based platform for proving a persons test results and vaccination status. Meanwhile, Vibrent Health aims to use mobile apps for identifying COVID-19 cases and using WiFi to perform contract tracing.

physIQ is planning an AI-based monitoring platform tied to wearable devices that would track an individuals health changes in the days following a positive test resultwhile Shee Atik Enterprises plans to integrate Bluetooth-equipped thermometers and pulse oximeters into a system designed for low-resource settings and underserved populations.

Finally, the University of California, San Francisco, is developing a GPS-based contact tracing tool for alerting users about potential exposures, and identifying businesses that were visited by someone who later tested positive for COVID-19. The system would then connect those businesses with public health departments for implementing strategies to reduce the spread of the virus.

RELATED: BARDA taps Evidation Health to digitally monitor healthcare workers for early COVID-19 symptoms

Digital health technologies built around smartphones and wearable devices will play an essential role in guiding us through the COVID-19 pandemic, said Bruce Tromberg, director of the National Institute of Biomedical Imaging and Bioengineering.

These platforms can acquire large amounts of data from many different sources spanning from testing technologies to sensors, Tromberg said. When this information is analyzed using cutting-edge computational and machine learning methods, everyone will have access to powerful new tools for reducing the risk of infection and returning to normal activities.

In a separate effort, the NIBIB awarded a contract to CareEvolution for SAFER-COVID, a digital health solution that uses self-reported symptoms, wearable-generated data, electronic health records and test results to determine when users should return to work and normal social activities.

All of the proposed digital health tools will be developed using multiple data sources, and each participating organization will share data and other assets through an NIH-supported central data hub, in ways that protect individuals privacy. In addition, researchers developing further projects will have access to data stored in the hub, the NIH said.

Read more from the original source:
NIH to fund 7 digital health projects aimed at COVID-19 - FierceBiotech

Analyzing Impacts Of Covid-19 On Laboratory Compressors And Pumps Market Effects, Aftermath And Forecast To 2026 – The Daily Chronicle

Posted on by

Overview for Laboratory Compressors And Pumps Market Helps in providing scope and definitions, Key Findings, Growth Drivers, and Various Dynamics.

Laboratory Compressors And Pumps Market Data and Acquisition Research Study with Trends and Opportunities 2019-2024The study of Laboratory Compressors And Pumps market is a compilation of the market of Laboratory Compressors And Pumps broken down into its entirety on the basis of types, application, trends and opportunities, mergers and acquisitions, drivers and restraints, and a global outreach. The detailed study also offers a board interpretation of the Laboratory Compressors And Pumps industry from a variety of data points that are collected through reputable and verified sources. Furthermore, the study sheds a lights on a market interpretations on a global scale which is further distributed through distribution channels, generated incomes sources and a marginalized market space where most trade occurs.

Along with a generalized market study, the report also consists of the risks that are often neglected when it comes to the Laboratory Compressors And Pumps industry in a comprehensive manner. The study is also divided in an analytical space where the forecast is predicted through a primary and secondary research methodologies along with an in-house model.

Download PDF Sample of Laboratory Compressors And Pumps Market report @ https://hongchunresearch.com/request-a-sample/80224

Key players in the global Laboratory Compressors And Pumps market covered in Chapter 4:Hangzhou Tailin Bioengineering EquipmentsJUN-AIR International A/SGardner DenverHeidolphCoaireGeneral europe vacuumHirschmann

In Chapter 11 and 13.3, on the basis of types, the Laboratory Compressors And Pumps market from 2015 to 2026 is primarily split into:Vacuum pumpsLaboratory peristaltic pumpsCompressorsVacuum systems

In Chapter 12 and 13.4, on the basis of applications, the Laboratory Compressors And Pumps market from 2015 to 2026 covers:Lab Instruments

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:North America (Covered in Chapter 6 and 13)United StatesCanadaMexicoEurope (Covered in Chapter 7 and 13)GermanyUKFranceItalySpainRussiaOthersAsia-Pacific (Covered in Chapter 8 and 13)ChinaJapanSouth KoreaAustraliaIndiaSoutheast AsiaOthersMiddle East and Africa (Covered in Chapter 9 and 13)Saudi ArabiaUAEEgyptNigeriaSouth AfricaOthersSouth America (Covered in Chapter 10 and 13)BrazilArgentinaColumbiaChileOthers

For a global outreach, the Laboratory Compressors And Pumps study also classifies the market into a global distribution where key market demographics are established based on the majority of the market share. The following markets that are often considered for establishing a global outreach are North America, Europe, Asia, and the Rest of the World. Depending on the study, the following markets are often interchanged, added, or excluded as certain markets only adhere to certain products and needs.

Here is a short glance at what the study actually encompasses:Study includes strategic developments, latest product launches, regional growth markers and mergers & acquisitionsRevenue, cost price, capacity & utilizations, import/export rates and market shareForecast predictions are generated from analytical data sources and calculated through a series of in-house processes.

However, based on requirements, this report could be customized for specific regions and countries.

Brief about Laboratory Compressors And Pumps Market Report with [emailprotected] https://hongchunresearch.com/report/laboratory-compressors-and-pumps-market-size-2020-80224

Some Point of Table of Content:

Chapter One: Report Overview

Chapter Two: Global Market Growth Trends

Chapter Three: Value Chain of Laboratory Compressors And Pumps Market

Chapter Four: Players Profiles

Chapter Five: Global Laboratory Compressors And Pumps Market Analysis by Regions

Chapter Six: North America Laboratory Compressors And Pumps Market Analysis by Countries

Chapter Seven: Europe Laboratory Compressors And Pumps Market Analysis by Countries

Chapter Eight: Asia-Pacific Laboratory Compressors And Pumps Market Analysis by Countries

Chapter Nine: Middle East and Africa Laboratory Compressors And Pumps Market Analysis by Countries

Chapter Ten: South America Laboratory Compressors And Pumps Market Analysis by Countries

Chapter Eleven: Global Laboratory Compressors And Pumps Market Segment by Types

Chapter Twelve: Global Laboratory Compressors And Pumps Market Segment by Applications12.1 Global Laboratory Compressors And Pumps Sales, Revenue and Market Share by Applications (2015-2020)12.1.1 Global Laboratory Compressors And Pumps Sales and Market Share by Applications (2015-2020)12.1.2 Global Laboratory Compressors And Pumps Revenue and Market Share by Applications (2015-2020)12.2 Lab Instruments Sales, Revenue and Growth Rate (2015-2020)

Chapter Thirteen: Laboratory Compressors And Pumps Market Forecast by Regions (2020-2026) continued

Check [emailprotected] https://hongchunresearch.com/check-discount/80224

List of tablesList of Tables and FiguresTable Global Laboratory Compressors And Pumps Market Size Growth Rate by Type (2020-2026)Figure Global Laboratory Compressors And Pumps Market Share by Type in 2019 & 2026Figure Vacuum pumps FeaturesFigure Laboratory peristaltic pumps FeaturesFigure Compressors FeaturesFigure Vacuum systems FeaturesTable Global Laboratory Compressors And Pumps Market Size Growth by Application (2020-2026)Figure Global Laboratory Compressors And Pumps Market Share by Application in 2019 & 2026Figure Lab Instruments DescriptionFigure Global COVID-19 Status OverviewTable Influence of COVID-19 Outbreak on Laboratory Compressors And Pumps Industry DevelopmentTable SWOT AnalysisFigure Porters Five Forces AnalysisFigure Global Laboratory Compressors And Pumps Market Size and Growth Rate 2015-2026Table Industry NewsTable Industry PoliciesFigure Value Chain Status of Laboratory Compressors And PumpsFigure Production Process of Laboratory Compressors And PumpsFigure Manufacturing Cost Structure of Laboratory Compressors And PumpsFigure Major Company Analysis (by Business Distribution Base, by Product Type)Table Downstream Major Customer Analysis (by Region)Table Hangzhou Tailin Bioengineering Equipments ProfileTable Hangzhou Tailin Bioengineering Equipments Production, Value, Price, Gross Margin 2015-2020Table JUN-AIR International A/S ProfileTable JUN-AIR International A/S Production, Value, Price, Gross Margin 2015-2020Table Gardner Denver ProfileTable Gardner Denver Production, Value, Price, Gross Margin 2015-2020Table Heidolph ProfileTable Heidolph Production, Value, Price, Gross Margin 2015-2020Table Coaire ProfileTable Coaire Production, Value, Price, Gross Margin 2015-2020Table General europe vacuum ProfileTable General europe vacuum Production, Value, Price, Gross Margin 2015-2020Table Hirschmann ProfileTable Hirschmann Production, Value, Price, Gross Margin 2015-2020Figure Global Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure Global Laboratory Compressors And Pumps Revenue ($) and Growth (2015-2020)Table Global Laboratory Compressors And Pumps Sales by Regions (2015-2020)Table Global Laboratory Compressors And Pumps Sales Market Share by Regions (2015-2020)Table Global Laboratory Compressors And Pumps Revenue ($) by Regions (2015-2020)Table Global Laboratory Compressors And Pumps Revenue Market Share by Regions (2015-2020)Table Global Laboratory Compressors And Pumps Revenue Market Share by Regions in 2015Table Global Laboratory Compressors And Pumps Revenue Market Share by Regions in 2019Figure North America Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure Europe Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure Asia-Pacific Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure Middle East and Africa Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure South America Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure North America Laboratory Compressors And Pumps Revenue ($) and Growth (2015-2020)Table North America Laboratory Compressors And Pumps Sales by Countries (2015-2020)Table North America Laboratory Compressors And Pumps Sales Market Share by Countries (2015-2020)Figure North America Laboratory Compressors And Pumps Sales Market Share by Countries in 2015Figure North America Laboratory Compressors And Pumps Sales Market Share by Countries in 2019Table North America Laboratory Compressors And Pumps Revenue ($) by Countries (2015-2020)Table North America Laboratory Compressors And Pumps Revenue Market Share by Countries (2015-2020)Figure North America Laboratory Compressors And Pumps Revenue Market Share by Countries in 2015Figure North America Laboratory Compressors And Pumps Revenue Market Share by Countries in 2019Figure United States Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure Canada Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure Mexico Laboratory Compressors And Pumps Sales and Growth (2015-2020)Figure Europe Laboratory Compressors And Pumps Revenue ($) Growth (2015-2020)Table Europe Laboratory Compressors And Pumps Sales by Countries (2015-2020)Table Europe Laboratory Compressors And Pumps Sales Market Share by Countries (2015-2020)Figure Europe Laboratory Compressors And Pumps Sales Market Share by Countries in 2015Figure Europe Laboratory Compressors And Pumps Sales Market Share by Countries in 2019Table Europe Laboratory Compressors And Pumps Revenue ($) by Countries (2015-2020)Table Europe Laboratory Compressors And Pumps Revenue Market Share by Countries (2015-2020)Figure Europe Laboratory Compressors And Pumps Revenue Market Share by Countries in 2015Figure Europe Laboratory Compressors And Pumps Revenue Market Share by Countries in 2019Figure Germany Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure UK Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure France Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure Italy Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure Spain Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure Russia Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure Asia-Pacific Laboratory Compressors And Pumps Revenue ($) and Growth (2015-2020)Table Asia-Pacific Laboratory Compressors And Pumps Sales by Countries (2015-2020)Table Asia-Pacific Laboratory Compressors And Pumps Sales Market Share by Countries (2015-2020)Figure Asia-Pacific Laboratory Compressors And Pumps Sales Market Share by Countries in 2015Figure Asia-Pacific Laboratory Compressors And Pumps Sales Market Share by Countries in 2019Table Asia-Pacific Laboratory Compressors And Pumps Revenue ($) by Countries (2015-2020)Table Asia-Pacific Laboratory Compressors And Pumps Revenue Market Share by Countries (2015-2020)Figure Asia-Pacific Laboratory Compressors And Pumps Revenue Market Share by Countries in 2015Figure Asia-Pacific Laboratory Compressors And Pumps Revenue Market Share by Countries in 2019Figure China Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure Japan Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure South Korea Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure Australia Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure India Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure Southeast Asia Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure Middle East and Africa Laboratory Compressors And Pumps Revenue ($) and Growth (2015-2020) continued

About HongChun Research:HongChun Research main aim is to assist our clients in order to give a detailed perspective on the current market trends and build long-lasting connections with our clientele. Our studies are designed to provide solid quantitative facts combined with strategic industrial insights that are acquired from proprietary sources and an in-house model.

Contact Details:Jennifer GrayManager Global Sales+ 852 8170 0792[emailprotected]

NOTE: Our report does take into account the impact of coronavirus pandemic and dedicates qualitative as well as quantitative sections of information within the report that emphasizes the impact of COVID-19.

As this pandemic is ongoing and leading to dynamic shifts in stocks and businesses worldwide, we take into account the current condition and forecast the market data taking into consideration the micro and macroeconomic factors that will be affected by the pandemic.

More:
Analyzing Impacts Of Covid-19 On Laboratory Compressors And Pumps Market Effects, Aftermath And Forecast To 2026 - The Daily Chronicle

How to Live Longer: A Look at the Science Behind the Longevity Movement – Vogue

Posted on by

If fasting is not exactly your speed, diet is still tremendously important. As for what you should eat, the gold standard remains the Mediterranean dietone that is high in vegetables, fruits, whole grains, beans, nuts, seeds, and olive oil, and low on red meatthe only diet, says Barzilai, proven by clinical research to decrease cardiovascular mortality. A recent study in the medical journal Gut found that following it for just one year slowed the development of age-related inflammatory processes.

David Sinclair, Ph.D., Harvard geneticist and author of the bestseller Lifespan: Why We Ageand Why We Dont Have To, says the Mediterranean diet essentially tricks the body into thinking weve been doing exercise and fasting. Of course, this is not a permission slip for bottomless bowls of rigatoni; too much of a good thing is too much. Dan Buettner, the National Geographic Fellow who helped popularize the idea of the blue zonesthe five areas worldwide with the longest-lived denizenssays he follows a rule practiced by the residents of Okinawa, Japan, and stops eating when his stomach is 80 percent full. And perhaps consider occasionally skipping dessert: Research shows that sugar intake accelerates age-related inflammation. The more sugar you eat, the faster you age, says Robert Lustig, professor of pediatric endocrinology at the University of California, San Francisco. (The American Heart Association recommends that women keep it under six teaspoons per day.)

Other crucial life practices: adequate sleep and stress management. In blue zones, says Buettner, people downshift all day long, through prayer, meditation, or just taking naps. And scientists are also coming to more fully understand the role that other people play in prolonging life. A 2019 study in the journal SSM-Population Health found that social relationships significantly increase life span in older adults. Neuroscientist Daniel Levitin, author of this years Successful Aging, has found that friendships at age 80 are a bigger predictor of health than cholesterol level. Friends and even neighbors, he writes, protect your brain, while loneliness has been implicated in just about every medical problem you can think of.

But what about the factors you cant control? Most of us dont know whats lurking in our genome and are not often aware we might inherit some disease until we see the symptoms. That is changing, with tests that are leagues beyond 23andMe. The new Preventive Genomics Clinic at Brigham and Womens Hospital in Boston is the first academic clinic in the country to offer comprehensive DNA sequencing and interpretation of nearly 6,000 disease-associated genes, ranging from common cancers to the rare Fabry disease, which impairs fat breakdown in cells and affects the heart. Roughly 20 percent of people will be carrying a variant for a rare disease, such as hereditary heart problems, says director Robert Green, M.D., medical geneticist at Brigham and Womens. Where a full panel of tests used to cost many hundreds of thousands of dollars, the clinic charges $250 for a smaller panel and $1,900 for full sequencing and interpretation. (These costs are not yet covered by most insurance.)

In the near future, says Barzilai as we finish our walk, we can be healthy and vital in our 90s and beyond. He laughs. It may sound like science fiction, but I promise you, its science. While I can comprehend the misgivings about prolonging life, Ill admit that Im still programmed to crave those extra years, and will adopt what changes I can to make them more vibrant. My role model here is Gloria Steinem, now 86. I plan to live to be 100, she once remarked. Which I would have to do anyway, just to meet my deadlines.

View original post here:
How to Live Longer: A Look at the Science Behind the Longevity Movement - Vogue

Robert E. Windsor, MD, is being recognized by Continental Who’s Who – PRNewswire

Posted on by

ALPHARETTA,Ga., Sept. 21, 2020 /PRNewswire/ --Robert E. Windsor, MD, is being recognized by Continental Who's Who as a Distinguished Leader for his remarkable contributions in the field of Medicine and for his dedication and commitment as the President, Medical Director, and Regenerative Medicine Specialist at Georgia RegenRX.

Located in the greater Atlanta area at 5755 North Point Pkwy, Suite #72, Alpharetta, Georgia, Georgia RegenRX offers expert, caring pain management and regenerative medical services to the Atlanta metropolitan area. Dr. Windsor plans to expand his practice into all aspects of regenerative medicine to include aesthetics and life extension. He believes that people do not need to age physiologically nearly as rapidly as they traditionally have and that they should remain mentally and physically vital and continue to look good while they age. An acclaimed physician, he has helped thousands of patients recover from the pain and improve their quality of life.

Backed by more than three decades of experience, Dr. Windsor is a top physician in Fulton County and will be expanding his practice into Forsyth and Gwinnett counties in 2021. His areas of expertise include interventional pain medicine, interventional orthopedics, regenerative medicine (e.g., stem cell therapy), integrative medicine, longevity medicine, and pain management for arthritis, chronic spinal pain, and sports injuries. In addition to his administrative and clinical experience, he has held numerous faculty positions. He has been a Pain Management Fellowship Director at Emory University, a leader at the American Academy of Physical Medicine, and a Visiting Professor at the University of Pennsylvania and Temple University among others.

Pursuing a pain/rehabilitative/physical medicine career to help others, Dr. Windsor always keeps, "the patient first and foremost." He has been highly successful because he continues to learn and develops new and improved skill sets. He advises new doctors to, "Stay up to date on emerging technologies in the biological field (i.e.: Stem cells)". He loves his field, remaining in his career for so many years because of his fervor for improving the function and quality of life of injured, ill, and/or elderly people.

In preparation for his career, Dr. Windsor earned a medical degree from the Texas A&M University College of Medicine at the age of twenty-three. He went on to complete a competitive residency program in physical medicine and rehabilitation at the University of Texas Health Sciences Center at San Antonio. Then, he earned board certification in Physical Medicine, Electrodiagnostic Medicine, Pain Medicine, Pain Management, Age Management Medicine, and Regenerative Medicine and he is currently completing a fellowship in Aesthetic Medicine.

A frontrunner in his field, Dr. Windsor has been board certified by the American Board of Physical Medicine, American Board of Pain Medicine, American Board of Pain Management, American Board of Electrodiagnostic Medicine, American Board of Age Management Medicine, and the American Board of Regenerative Medicine. In appreciation of his service, Dr. Windsor was honored as America's Top Physician by the Consumers Research Council of America in 2014. The President of PASSOR, he has received the following PASSOR awards: Distinguished Clinician, Distinguished Committee, and Distinguished Member. He has been active in his field throughout his career, having previously served as the past-Executive Board Member of the AAPM&R.

A lifelong athlete, Dr. Windsor enjoys staying active. He likes lifting weights, snow skiing, scuba diving, boating, and skydiving. He is heavily involved with his family. He has many offspring, several of whom are engaged in the medical field.

Dr. Windsor dedicates this recognition to Stanley Herring, MD, Richard Derby, MD, Charles April, MD, and Daniel Dumitru, MD, Ph.D. For more information, please visit https://www.garegenrx.com

Contact: Katherine Green, 516-825-5634[emailprotected]

SOURCE Continental Who's Who

https://www.garegenrx.com

See the original post here:
Robert E. Windsor, MD, is being recognized by Continental Who's Who - PRNewswire